MedPath

Neuromodulation With rTMS in Dysphagic Patients With Stroke

Not Applicable
Completed
Conditions
Transcranial Magnetic Stimulation
Interventions
Device: repetitive transcranial magnetic stimulation
Registration Number
NCT02893033
Lead Sponsor
Taipei Veterans General Hospital, Taiwan
Brief Summary

The patients with chronic dysphagia secondary to first-ever stroke were randomly assigned to 2 groups: Group A: sham stimulation for 10 minutes , Group B: real rTMS for 10 minutes. rTMS conditioning: daily rTMS 10 min for 10 days. Assessments: 1. videofluoroscopy,2.Functional outcome swallowing scale (3 scales). 3. MEP measurements

Detailed Description

While the reflex component of swallowing depends on swallowing centres in the brainstem, initiation of swallowing is a voluntary action that involves the integrity of motor areas of the cerebral cortex. Oropharyngeal dysphagia occurs in more than 50% of stroke patients. Aspiration pneumonia occurs in up to 20% of acute stroke patients and is a major cause of mortality after discharge. Oropharyngeal dysphagia is both underestimated and underdiagnosed as a cause of major nutritional and respiratory complications in stroke patients. Recently, transcranial magnetic stimulation (TMS) has been used to study the cortical input to swallowing control and has revealed that the topographic representation of esophageal motor function in the human cerebral cortex is bilateral but with consistent interhemispheric asymmetry unrelated to handedness.

In a number of recent studies, poststroke motor and dysphagia performance has been improved after daily treatment sessions with repetitive TMS (rTMS) using an excitatory frequency in patients with hemispheric ischaemic stroke due to occlusion of territories of the middle cerebral artery. Our hypothesis was that rTMS would facilitate dysphagia recovery.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
5
Inclusion Criteria
  1. a diagnosis of stroke related dysphagia
  2. no concurrent neurodegenerative or dementia history
  3. an absence of TMS contraindications.
Exclusion Criteria
  • arrythmia, epilepsy, infection, hyperglycemia, pacemaker or implants, external ventricular drain or ventriculoperitoneal shunt

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Real stimulationrepetitive transcranial magnetic stimulationReal repetitive transcranial magnetic stimulation + swallowing training
Sham stimulationrepetitive transcranial magnetic stimulationSham repetitive transcranial magnetic stimulation + swallowing training
Primary Outcome Measures
NameTimeMethod
functional outcomeprior to treatment (baseline), on the next day after the 2 weeks treatment completion

points of Australian Therapy Outcome Measures-the Swallowing scale as assessed by a clinical therapist

Secondary Outcome Measures
NameTimeMethod
videofluoroscopyprior to treatment (baseline), on the next day after the 2 weeks treatment completion

points of Penetration-Aspiration Scale as assessed by videofluoroscopy

cricopharyngeal motor evoked potentialsprior to treatment (baseline), on the next day after the 2 weeks treatment completion

amplitude and latency measured by cricopharyngeal motor evoked potentials

© Copyright 2025. All Rights Reserved by MedPath